Atlas Trials

A Study of LY2801653 in Advanced Cancer

Clinical trial NCT01285037 · COMPLETED

Trial details

NCT number
NCT01285037
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cancer
Start date
2009-09-09
Primary completion
2017-07-21
Enrollment
190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.